Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects

被引：0
|
作者：
Rebecca E. Wrishko
Jacqueline B. McCrea
Ka Lai Yee
Wen Liu
Deborah Panebianco
Eric Mangin
Manu Chakravarthy
Maria P. Martinez-Cantarin
Walter K. Kraft
机构：
[1] Merck & Co.,Department of Pharmacology and Experimental Therapeutics
[2] Inc.,undefined
[3] Thomas Jefferson University,undefined
来源：
Clinical Drug Investigation | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original version of this article unfortunately contained a mistake
引用
收藏
页码：453 / 454
页数：1
相关论文
共 50 条
  • [31] An open-label study to explore the optimal design of CYP3A drug-drug interaction clinical trials in healthy Chinese people
    Chen, Jingcheng
    Li, Jiangshuo
    Wu, Jingxuan
    Song, Yuqin
    Li, Lijun
    Zhang, Jianxiong
    Dong, Ruihua
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (04):
  • [32] Effect of Multiple Oral Doses of Linagliptin on the Steady-State Pharmacokinetics of a Combination Oral Contraceptive in Healthy Female AdultsAn Open-Label, Two-Period, Fixed-Sequence, Multiple-Dose Study
    Christian Friedrich
    Andreas Port
    Arne Ring
    Ulrike Graefe-Mody
    Thomas Giessmann
    Mario Iovino
    Hans-Juergen Woerle
    Clinical Drug Investigation, 2011, 31 : 643 - 653
  • [33] Effect of Multiple Oral Doses of Linagliptin on the Steady-State Pharmacokinetics of a Combination Oral Contraceptive in Healthy Female Adults An Open-Label, Two-Period, Fixed-Sequence, Multiple-Dose Study
    Friedrich, Christian
    Port, Andreas
    Ring, Arne
    Graefe-Mody, Ulrike
    Giessmann, Thomas
    Iovino, Mario
    Woerle, Hans-Juergen
    CLINICAL DRUG INVESTIGATION, 2011, 31 (09) : 643 - 653
  • [34] Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects
    Luckey, Alison
    Alirol, Emilie
    Delhomme, Sophie
    O'Donnell, John
    Bettiol, Esther
    Mueller, John
    O'Brien, Seamus
    Gillon, Jean-Yves
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (05): : 770 - 780
  • [35] The pharmacokinetics of pamiparib in the presence of a strong CYP3A inhibitor (itraconazole) and strong CYP3A inducer (rifampin) in patients with solid tumors: an open-label, parallel-group phase 1 study
    Song Mu
    Chester Lin
    Anna Skrzypczyk-Ostaszewicz
    Iurie Bulat
    Marina Maglakelidze
    Viera Skarbova
    Claudia Andreu-Vieyra
    Srikumar Sahasranaman
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 81 - 88
  • [36] The pharmacokinetics of pamiparib in the presence of a strong CYP3A inhibitor (itraconazole) and strong CYP3A inducer (rifampin) in patients with solid tumors: an open-label, parallel-group phase 1 study
    Mu, Song
    Lin, Chester
    Skrzypczyk-Ostaszewicz, Anna
    Bulat, Iurie
    Maglakelidze, Marina
    Skarbova, Viera
    Andreu-Vieyra, Claudia
    Sahasranaman, Srikumar
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (01) : 81 - 88
  • [37] Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study
    Wang, Wei
    Qian, Hong-jie
    Xin, Liang
    Zhang, Meng-qi
    Lu, Dong-ying
    Jin, Jie-mei
    Liu, Gang-yi
    Jia, Jing-ying
    Zheng, Hong-chao
    Yu, Chen
    Wang, Yi-ping
    Zhu, Fu
    Liu, Yun
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (04) : 593 - 599
  • [38] A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects
    Sun, Lei
    McDonnell, David
    Yu, Miao
    Kumar, Vipul
    von Moltke, Lisa
    CLINICAL DRUG INVESTIGATION, 2019, 39 (05) : 477 - 484
  • [39] Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study
    Wei Wang
    Hong-jie Qian
    Liang Xin
    Meng-qi Zhang
    Dong-ying Lu
    Jie-mei Jin
    Gang-yi Liu
    Jing-ying Jia
    Hong-chao Zheng
    Chen Yu
    Yi-ping Wang
    Fu Zhu
    Yun Liu
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 593 - 599
  • [40] A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects
    Lei Sun
    David McDonnell
    Miao Yu
    Vipul Kumar
    Lisa von Moltke
    Clinical Drug Investigation, 2019, 39 : 477 - 484
12345